VT:At the orders of Donald Trump, the US government has only purchased enough vaccines for 12 percent of the population. Pfizer has sold 300,00 million doses to be delivered outside the US, all manufactured at their plant in Kalamazoo, Michigan.
tRUMP TURNED DOWN ADDITIONAL DOSES OF VACCINE FROM PFIZER pic.twitter.com/Bt0VuTnkq9— Michal (@MichalKleinRN) December 7, 2020
COVID deaths, now closing in on 4000 a day, will likely continue until fall of 2021 along with the lockdowns instead of coming to a close by the end of February. Trump partners and family members are literally making a killing selling PPE and now proven useless ventilators, a business that will continue much longer than it should have, thanks to Donald Trump.
NEW: The Trump administration declined an offer from Pfizer late this summer for additional doses of its coronavirus vaccine, a senior administration official confirmed to @ABC News. https://t.co/st9UdgdasR— ABC News (@ABC) December 7, 2020
Daily Beast: Trump administration officials turned down an offer from Pfizer to sell extra doses of the COVID-19 vaccine to the U.S., The New York Times reported on Monday.
BREAKING: Trump passed on buying more Pfizer vaccine.— Andy Slavitt @ 🏡🇺🇸 (@ASlavitt) December 7, 2020
Because of it, Pfizer can’t ship many doses to the US until June. https://t.co/Ss7wshymah
In July, the pharmaceutical company announced a deal with the U.S. government for an initial shipment of 100 million doses; enough to inoculate 50 million people, as the vaccine is administered in two shots.
It is unknown how many additional doses were in Pfizer’s offer, which was given sometime in the late summer, according to the Times. Given Pfizer’s commitments with other nations, the United States may not be able to acquire extra doses of their vaccine until June, the Times wrote.
Breaking NYT: Trump officials passed when Pfizer offered in late summer to sell the U.S. government additional doses of its COVID vaccine.— Kyle Griffin (@kylegriffin1) December 7, 2020
Now Pfizer may not be able to provide more vaccine to the U.S. until June because of commitments to other countries. https://t.co/jC01GdH9wP
Another vaccine, produced by Moderna, is currently awaiting emergency FDA approval, expected sometime later this month.